This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Peptide therapy overview
An evidence-first overview of peptide therapy: what it is, which peptides are approved, and how to tell legitimate clinical care from research-chemical marketing.
Quick answer
Peptide therapy uses short amino-acid chains for effects ranging from tissue repair to growth-hormone release. Only a few peptides are FDA-approved finished drugs; most marketed for wellness are unapproved. Legitimacy depends on a licensed clinician, a licensed pharmacy, and honest evidence claims.
Where should you read next?
BPC-157
Tissue-repair marketing, minimal human data
TB-500
Recovery claims, research-chemical sales
Sermorelin
GHRH analog
Tesamorelin
Approved for HIV-lipodystrophy
Research vs prescription peptides
The legal and safety line
Verify a peptide provider
A checklist
Sources
- U.S. Food and Drug Administration — approval and compounding status.
- Primary clinical literature cited on child pages.
- Our methodology and source standards.
How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.